王進富 David (Chin- Fu) Wang
Founder & Chairman of Sunmax Biotech (TWSE. 4728)
Vice-Chairman of GenMont Biotech Incorporation (TWSE.3164)
Vice-Chairman of ALLIED INDUSTRIAL CORP., LTD (TWSE. 4702)
陳克華 Ke-Hua Chen MD
Clinical Lead Investigator
Head & Chief Physician, Ophthalmology, Taipei Veterans Hospital.
Associate Professor, Ophthalmology, National Yang Ming University.
Researcher, Schepens Eye Research Institute, Harvard University.
林峰輝 博士 Dr. Feng-Huei Lin
Chair of the Scientific Advisory Board
Tenure Distinguished Professor, Biomedical Engineering, National Taiwan University.
Former Director, Biomedical Engineering & Nanomedicine, NHRI Taiwan.
Executive Yuan Member, National Science & Technology Review Board.
王進賢 博士 Jinn-Shyan Wan, Ph.D.
Clinical Advisor
Co-chair of the Scientific Advisory Board, Visionary BioMed Limited TW
Professor, Biochemistry, Department of Medicine, Fu-Jen Catholic University
Associate Dean, College of Medicine, Fu-Jen Catholic University
李憶菁 教授 Yih-Jing Lee, PhD
Scientific Advisor
Professor in Physiology, School of Medicine, Fu-Jen Catholic University
Director, Center of Research Ethics, Fu-Jen Catholic University
Vice Dean, Office of Research and Development, Fu-Jen Catholic University
王詩晴 Joice Wang
CEO & Co-founder
Board of Director & Head of Global BD, Sunmax Biotech (TWSE.4728)
Head of Investor Relations & CEO Office, CG Oncology (NASDAQ: CGON)
Head of Investor Relations, IVC VC Fund
鄭仲志 博士 Allen Cheng, PhD
CTO & Head of Regulatory
Director, Medical and Pharmaceutical Industry Technology and Development Center of Taiwan
Board Member, Taiwan Science & Technology Development Foundation
Board Supervisor, CellEnvision Company Limited
吳源逸 Ian Wu
Head of Research and Development
Deputy R&D Manager, VisionaryBioMed Co., Ltd.
R&D Engineer, Double Bond Chemical Ind. Co., Ltd.
MS, Institute of Clinical Medicine, National Yang Ming Chiao Tung University
蔡有翔 Jack Tsai
Director of R&D and CMC
6 IRB-approved clinical trial cases at Taipei Veterans General Hospital, CMC documentation
5 years of experiences in cell therapy related preclinical animal studies
MS in Biotechnology, China Medical University
愷威 KaiWei, Lin
Head of Clinical
Achieved successful completion of US FDA, NMPA, PMDA and TFDA inspection
Completed nearly 10 clinical trial programs in support of European drug registrations
Assisted 5 Hospital for a clinical trial center in compliance with USFDA requirements
Jimmy Liu
CSO
Cofounder & Board of Director, Visionary Biomed Limited
General Manager & Board of Director, GLYCONEX INCORPORATION (TWSE. 4168)
General Manager & Board of Director, Double Bond Chemical Ind Co Ltd (TWSE.4764)
紀玉玲 YuLing Chi
Secretary to the Board
Executive Assistant to Chairman, Visionary BioMed Limited
Personal Assistant to Chairman, Visionary Biomed Limited
Executive Assistant to Chairman, Sunmax Biotech (TWSE.4728)
林仲威 Will Lin
Chief of Staff & Director of finance
Special Assistant to the Chairman,Visionary Biomed Limited
Strategic Planning Associate, E.SUN Securities
Assistant Manager, Financial Advisory Division, E.SUN
We are advancing patient-derived epithelial cell-sheet therapy with discipline, clarity, and clinical focus.
Taipei, Taiwan
